Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cyclohexanol | HCID 7966 | — |
| Reactant | HCID 54532449 | HCID 54532449 | — |
| Catalyst | Titanium(IV)ethoxide | HCID 2724286 | — |
| Solvent | Potassium Fluoride | HCID 522689 | — |
| Product | HCID 53848100 | HCID 53848100 | — |
Reaction Steps
12 g (26.6 mmol) of tert.butyl (S)-12,12a-dihydro-8-iodo-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate, 70 ml (660 mmol) of cyclohexanol and 2 g (8 mmol) of tetraethyl orthotitanate are stirred at 120° overnight, the solution is evaporated to dryness and the residue is taken up in chloroform. The solution obtained is stirred for 0.5 hour with 120 ml of a saturated potassium fluoride solution, the resulting emulsion is filtered through siliceous earth, the organic phase is separated, washed with water, dried over magnesium sulphate and evaporated. By crystallization from ethyl acetate and hexane there is obtained cyclohexyl (S)-12,12a-dihydro-8-iodo-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate of melting point 124°-125°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04489003 |
|---|
| Source dataset | uspto-grants-1984_12 |
|---|
| ORD ID | ord-fa13f76bf100471590a8c372df2d440f |
|---|
| Source note | uspto-grants-1984_12 |
|---|